DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,054 filers reported holding DANAHER CORPORATION in Q4 2021. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $76,346,007 | +1.5% | 307,723 | -1.8% | 1.11% | +16.9% |
| Q2 2023 | $75,222,543 | -5.8% | 313,427 | -1.1% | 0.95% | -15.4% |
| Q1 2023 | $79,864,439 | +93385.2% | 316,872 | -1.6% | 1.12% | -12.7% |
| Q4 2022 | $85,430 | -99.9% | 321,868 | -2.0% | 1.28% | +1.8% |
| Q3 2022 | $84,846,000 | -47.7% | 328,490 | -48.7% | 1.26% | +2.8% |
| Q2 2022 | $162,338,000 | +62.5% | 640,338 | +88.0% | 1.23% | +8.6% |
| Q1 2022 | $99,885,000 | -14.7% | 340,521 | -4.3% | 1.13% | -2.5% |
| Q4 2021 | $117,085,000 | +5.3% | 355,870 | -2.6% | 1.16% | +3.9% |
| Q3 2021 | $111,208,000 | +14.4% | 365,286 | +0.8% | 1.12% | +13.0% |
| Q2 2021 | $97,229,000 | +23.1% | 362,306 | +3.2% | 0.99% | +9.7% |
| Q1 2021 | $79,005,000 | +4.8% | 351,007 | +3.5% | 0.90% | +8.0% |
| Q4 2020 | $75,372,000 | +6.2% | 339,299 | +3.0% | 0.83% | -15.9% |
| Q3 2020 | $70,948,000 | +25.4% | 329,486 | +3.0% | 0.99% | +11.5% |
| Q2 2020 | $56,557,000 | +33.5% | 319,837 | +4.5% | 0.89% | +0.1% |
| Q1 2020 | $42,373,000 | -9.3% | 306,139 | +0.6% | 0.89% | +5.7% |
| Q4 2019 | $46,722,000 | +52.9% | 304,418 | +43.8% | 0.84% | +44.9% |
| Q3 2019 | $30,565,000 | +2.7% | 211,623 | +1.7% | 0.58% | +2.8% |
| Q2 2019 | $29,748,000 | – | 208,141 | – | 0.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |